A Phase I Trial of ZIO-101 in Hematologic Cancers

Clinical trial NCT00592046 · COMPLETED

Trial details

NCT number: NCT00592046
Sponsor: Alaunos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia Chronic Myeloproliferative Disease Chronic Lymphoproliferative Disease Multiple Myeloma Lymphoma Poor-risk Myelodysplasia (MDS)

Start date: 2005-05-01
Primary completion: 2008-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.